DÜSSELDORF (dpa-AFX) – According to a press report, the activist investor Bluebell is gathering allies to enforce its demands for changes at the pharmaceutical and agrochemical group Bayer. Since it became known that Bluebell was involved with Bayer, many investors had approached the activist, a person familiar with the matter told the “Handelsblatt”. These investors have “the same thoughts” and complained about the weak share price. The Bloomberg news agency reported on Bluebell’s entry in mid-January. Shortly before that, the activist investor Jeff Ubben and his hedge fund Inclusive Capital had announced an investment in the Dax group.
While Inclusive Capital is primarily concerned with an external successor for Bayer boss Werner Baumann, who will leave by 2024 at the latest, Bluebell pushed for a split of the Dax (DAX 40) group, according to the Bloomberg report. However, such demands are not new. According to the “Handelsblatt”, however, Bluebell is now also demanding that the chief post be filled quickly with an external candidate.
It is actually official that Bayer boss Werner Baumann, who has often been criticized for the costly Monsanto takeover and the billion-dollar glyphosate legal dispute brought into the company, will leave in 2024.
Bluebell is a fairly small fund, but it’s notorious for being aggressive. In 2021, despite only having a very small stake in the food company Danone, Bluebell became the mouthpiece of many frustrated investors who called for the resignation of the then CEO Emmanuel Faber, who ultimately had to resign./mis
Leverage must be between 2 and 20
No data
